Marta Krawczyk

5 Adolfa Pawinskiego St
Warsaw, MZ 02106, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction to: GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis.

Correction to: GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis.

Journal: Cancer immunology, immunotherapy : CII

Published: April 07, 2026

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Journal: Leukemia

Published: March 11, 2026

Beyond Biochemical Markers: Characterizing Malnutrition in COVID-19.

Beyond Biochemical Markers: Characterizing Malnutrition in COVID-19.

Journal: Nutrients

Published: October 17, 2025

The race between 4-1BB- and CD28-based CD19 CAR-T products in the therapy of B-cell malignancies.

The race between 4-1BB- and CD28-based CD19 CAR-T products in the therapy of B-cell malignancies.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: July 16, 2025

GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis.

GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis.

Journal: Cancer immunology, immunotherapy : CII

Published: April 25, 2025

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Journal: bioRxiv : the preprint server for biology

Published: March 17, 2025

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Journal: Leukemia

Published: September 06, 2024

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Journal: Oncoimmunology

Published: June 07, 2024

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Journal: Cancer research

Published: March 04, 2024

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Journal: The Journal of biological chemistry

Published: November 17, 2022

CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Journal: Cells

Published: April 27, 2022

Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Journal: International journal of molecular sciences

Published: December 22, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026